
Release date: 2026-01-13 17:34:40 Article From: Lucius Laos Recommended: 132
This medicine may affect your blood glucose levels. If you experience increased thirst or frequent urination, consult your doctor immediately. If you notice any changes in your urine or blood glucose test results, or have any questions, please consult your doctor.
It is crucial that your doctor monitors your condition regularly to detect any potential problems caused by this medicine. Blood tests may be required to monitor for adverse effects.
Use of this medicine during pregnancy may harm your unborn baby. If there is a possibility of you being pregnant, your doctor may perform a pregnancy test before you start treatment to confirm that you are not pregnant. Use effective contraception to avoid pregnancy during treatment with this medicine and for at least 1 month after the last dose. Male patients with female partners should use effective contraception during treatment with this medicine and for at least 4 months after the last dose. If you think you may have become pregnant while taking this medicine, inform your doctor immediately.
You should take Capivasertib tablets on a cycle of 4 days on treatment followed by 3 days off treatment, twice daily. A 4-week (28-day) course of medication is defined as one treatment cycle.
Repeat this cycle thereafter.
Swallow the tablets whole with water. Do not chew, crush or split the tablets before swallowing. Do not take any tablets that are broken, cracked or damaged.
The recommended dose for most adults is 800 mg daily, which is 2 tablets of 200 mg each, twice daily, approximately 12 hours apart. It is advisable to take the medicine at fixed times every day.
You need to take Capivasertib in combination with fulvestrant.
Fulvestrant is administered by injection, with 2 injections per dose, one in each buttock. For the first three doses, fulvestrant is injected every 14 days; thereafter, during your continuous treatment with Capivasertib, the injection frequency is changed to once every 28 days.
If you miss a dose of Capivasertib, you may take the missed dose immediately within 4 hours of your usual dosing time.
If more than 4 hours have passed since your usual dosing time, skip the missed dose and take the next scheduled dose at your regular time. Please note that there should be an interval of at least 8 hours between two consecutive doses.
If you vomit after taking a dose, do not take an extra dose; simply take the next scheduled dose at the original time.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2622025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4832024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2672025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2772025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2582025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3032025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2652025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2442025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: